Peptide Based Gastrointestinal Disorders Therapeutics Market
Peptide Based Gastrointestinal Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022
Analysis of Peptide Based Gastrointestinal Disorders Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Inroduction
Pharmaceutical companies are increasingly collaborating with medical institutes and research centers in order to ramp up R&D pipelines of peptide drugs. This is expected to influence the growth of the global peptide based gastrointestinal disorders therapeutics market over the next couple of years.
Rising prevalence of metabolic diseases and gastrointestinal disorders pertaining to the digestive system is prompting medical practitioners to utilize new therapeutics including peptides. In the near future, application of peptides is also expected to increase in other therapeutic areas as well.
Moreover, technological advancement in peptide synthesis which include hybrid combination of liquid and solid synthesis and high-throughput approaches is expected to play a crucial role in development of more effective peptide based therapeutic drugs for treating gastrointestinal disorders.
Such developments in the peptide therapeutics is also giving new hope to patients seeking affordable and effect therapeutic treatments. In addition, manufacturers are actively focusing on improving peptide properties, such as half-life and stability to address the various unmet medical needs.
According to the latest report published by Fact.MR, the global peptide based gastrointestinal disorders therapeutics market is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn.
Peptide is a biologically, naturally or artificially constituted form of amino acid monomers. Peptides can be utilized for treating various gastrointestinal disorders that mostly effect parts of the digestive system such as the gastrointestinal tract, large intestine, small intestine, stomach, esophagus, and rectum.
Peptides are considered as an effective therapeutic agent for treating gastrointestinal diseases. Owing to their impressive preclinical results, an array of new peptide based gastrointestinal disorder therapeutics are expected to enter the market soon.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
North America to Lead the Global Peptide Based Gastrointestinal Disorders Therapeutics Market
In terms of revenue, North America is expected to hold the dominant share of the global peptide based gastrointestinal disorders therapeutics market in 2017 and beyond. Factors such growing patient awareness and rapid adoption of peptide based therapeutics for treating various diseases are expected to support the growth of the market in the region.
During the forecast period, the market in the region is projected to surge at a robust CAGR of 13.9%.
On the basis of drugs, the linaclotide segment is expected to retain its dominant position over 2022. Currently, the segment accounts for more than two-third share of the market in terms of revenue.
Towards the end of the forecast period, the linaclotide segment is estimated to reach a market valuation in excess of US$ 466 Mn.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Competition Tracking
- Shire plc
- Ironwood Pharmaceuticals, Inc.
- Astellas Pharma Inc.
- Allergan plc
- Accredo Health Group, Inc.,
are the key market players profiled in the Fact.MR’s report. A majority of these companies are channelizing investment in further expansion of their product portfolio.
This, in turn, is anticipated to result in introduction of more efficacious peptide based therapeutic drugs for curing gastrointestinal ailments.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Market Taxonomy
-
By Drug :
- Teduglutide
- Linaclotide
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
Table of Content
1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market - Executive Summary 2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Overview 2.1. Introduction 2.1.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Taxonomy 2.1.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Definition 2.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022 2.2.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Y-o-Y Growth 2.3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics 2.4. Regulations 2.5. Supply Chain 2.6. Cost Structure 2.7. Average Pricing Analysis 2.8. Epidemiology 2.9. Key Participants Market Presence (Intensity Map) By Region 3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Drug 3.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022 3.1.1. Teduglutide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 3.1.1.1. Revenue (US$ Mn) Comparison, By Region 3.1.1.2. Market Share Comparison, By Region 3.1.1.3. Y-o-Y growth Comparison, By Region 3.1.2. Linaclotide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 3.1.2.1. Revenue (US$ Mn) Comparison, By Region 3.1.2.2. Market Share Comparison, By Region 3.1.2.3. Y-o-Y growth Comparison, By Region 4. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Distribution Channel 4.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022 4.1.1. Hospital Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Retail Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Online Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Region 5.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.1. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.1.1. Revenue (US$ Mn) Comparison, By Drug 5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.2. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.2.1. Revenue (US$ Mn) Comparison, By Drug 5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.3. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.3.1. Revenue (US$ Mn) Comparison, By Drug 5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.4. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.4.1. Revenue (US$ Mn) Comparison, By Drug 5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.5. APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.5.1. Revenue (US$ Mn) Comparison, By Drug 5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.6. MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 5.1.6.1. Revenue (US$ Mn) Comparison, By Drug 5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 6. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 6.1. US Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 6.1.1. Revenue (US$ Mn) Comparison, By Drug 6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 6.2. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 6.2.1. Revenue (US$ Mn) Comparison, By Drug 6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 7.1. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 7.1.1. Revenue (US$ Mn) Comparison, By Drug 7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7.2. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 7.2.1. Revenue (US$ Mn) Comparison, By Drug 7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7.3. Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 7.3.1. Revenue (US$ Mn) Comparison, By Drug 7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 8.1. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.1.1. Revenue (US$ Mn) Comparison, By Drug 8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.2. UK Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.2.1. Revenue (US$ Mn) Comparison, By Drug 8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.3. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.3.1. Revenue (US$ Mn) Comparison, By Drug 8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.4. Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.4.1. Revenue (US$ Mn) Comparison, By Drug 8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.5. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.5.1. Revenue (US$ Mn) Comparison, By Drug 8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.6. Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 8.6.1. Revenue (US$ Mn) Comparison, By Drug 8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 9. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 9.1. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 9.1.1. Revenue (US$ Mn) Comparison, By Drug 9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10. APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 10.1. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.1.1. Revenue (US$ Mn) Comparison, By Drug 10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.2. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.2.1. Revenue (US$ Mn) Comparison, By Drug 10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.3. Malaysia Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.3.1. Revenue (US$ Mn) Comparison, By Drug 10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.4. Thailand Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.4.1. Revenue (US$ Mn) Comparison, By Drug 10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.5. Singapore Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.5.1. Revenue (US$ Mn) Comparison, By Drug 10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.6. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 10.6.1. Revenue (US$ Mn) Comparison, By Drug 10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11. MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022 11.1. GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 11.1.1. Revenue (US$ Mn) Comparison, By Drug 11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.2. South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 11.2.1. Revenue (US$ Mn) Comparison, By Drug 11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.3. Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 11.3.1. Revenue (US$ Mn) Comparison, By Drug 11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.4. Israel Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022 11.4.1. Revenue (US$ Mn) Comparison, By Drug 11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Competition Landscape and Company Profile 12.1. Company Share Analysis By Region 12.2. Shire plc 12.2.1. Company Overview 12.2.2. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug list 12.2.3. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug Sales Data and Key Financials 12.2.4. Key Developments 12.2.5. SWOT Analysis 12.3. Ironwood Pharmaceuticals, Inc 12.3.1. Company Overview 12.3.2. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug list 12.3.3. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug Sales Data and Key Financials 12.3.4. Key Developments 12.3.5. SWOT Analysis 12.4. Astellas Pharma Inc 12.4.1. Company Overview 12.4.2. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug list 12.4.3. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug Sales Data and Key Financials 12.4.4. Key Developments 12.4.5. SWOT Analysis 12.5. Allergan plc 12.5.1. Company Overview 12.5.2. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug list 12.5.3. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug Sales Data and Key Financials 12.5.4. Key Developments 12.5.5. SWOT Analysis 12.6. Accredo Health Group, Inc 12.6.1. Company Overview 12.6.2. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug list 12.6.3. Peptide Based Gastrointestinal Disorders Therapeutics Market Drug Sales Data and Key Financials 12.6.4. Key Developments 12.6.5. SWOT Analysis 13. Research Methodology 14. Secondary and Primary Sources 15. Assumptions and Acronyms 16. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 02: Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 :Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 04: Global Teduglutide Segment Value (US$ Mn), By Region 2012-2016
TABLE 05: Global Teduglutide Segment Value (US$ Mn), By Region 2017-2022
TABLE 06: Global Teduglutide Segment Market Share, By Region 2012-2016
TABLE 07: Global Teduglutide Segment Market Share, By Region 2017-2022
TABLE 08: Global Teduglutide Segment Y-o-Y, By Region 2015-2022
TABLE 09: Global Linaclotide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10: Global Linaclotide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11: Global Linaclotide Segment Market Share, By Region 2012-2016
TABLE 12: Global Linaclotide Segment Market Share, By Region 2017-2022
TABLE 13: Global Linaclotide Segment Y-o-Y, By Region 2015-2022
TABLE 14: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 16: Global Hospital Pharmacies Segment Market Share, By Region 2012-2016
TABLE 17: Global Hospital Pharmacies Segment Market Share, By Region 2017-2022
TABLE 18: Global Hospital Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 19: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 20: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 21: Global Retail Pharmacies Segment Market Share, By Region 2012-2016
TABLE 22: Global Retail Pharmacies Segment Market Share, By Region 2017-2022
TABLE 23: Global Retail Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 24: Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 25: Global Online Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 26: Global Online Pharmacies Segment Market Share, By Region 2012-2016
TABLE 27: Global Online Pharmacies Segment Market Share, By Region 2017-2022
TABLE 28: Global Online Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 29: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 30: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 31: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 32: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 33: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 34: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 35: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 36: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 37: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 38: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 39: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 40: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 41: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 42: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 43: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 44: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 45: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 46: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 47: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 48: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 49: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 50: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 51: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 52: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 53: US Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 54: US Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 55: US Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 56: US Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 57: Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 58: Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 59: Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 60: Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 61: Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 62: Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 63: Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 64: Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 65: Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 66: Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 67: Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 68: Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 69: Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 70: Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 71: Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 72: Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 73: Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 74: Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 75: Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 76: Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 77: UK Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 78: UK Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 79: UK Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 80: UK Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 81: France Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 82: France Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 83: France Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 84: France Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 85: Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 86: Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 87: Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 88: Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 89: Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 90: Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 91: Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 92: Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 93: Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 94: Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 95: Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 96: Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 97: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 98: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 99: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 100: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 101: China Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 102: China Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 103: China Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 104: China Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 105: India Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 106: India Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 107: India Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 108: India Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 109: Malaysia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 110: Malaysia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 111: Malaysia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 112: Malaysia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 113: Thailand Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 114: Thailand Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 115: Thailand Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 116: Thailand Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 117: Singapore Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 118: Singapore Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 119: Singapore Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 120: Singapore Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 121: Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 122: Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 123: Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 124: Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 125: GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 126: GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 127: GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 128: GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 129: South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 130: South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 131: South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 132: South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 133: Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 134: Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 135: Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 136: Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 137: Israel Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 138: Israel Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 139: Israel Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 140: Israel Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 01: Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 02: Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 03: Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 04: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 05: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 06: Global Teduglutide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 07: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 08: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 09: Global Linaclotide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 20: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 21: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 22: North America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 23: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 24: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 25: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 26: Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 27: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 28: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 29: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 30: Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 31: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 32: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 33: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 34: Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 35: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 36: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 37: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 38: APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 39: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 40: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 41: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 42: MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth prospect for the Peptide-based gastrointestinal disorders therapeutics market in North America by 2022?
With a CAGR of 13.9%, this market is showing robust prospects until 2022.
Which region is dominating the peptide-based gastrointestinal disorders therapeutics market?
North America is dominating this market during the forecast period of 2017-2022.
What is driving the demand for the peptide-based gastrointestinal disorders therapeutics market?
Rising prevalence of metabolic diseases and gastrointestinal disorders is driving demand for this market.
Peptide Based Gastrointestinal Disorders Therapeutics Market